BLONDENA MILEY: Open Payments
NPI 1013580687 · LAKE HAVASU CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 18 payments from 10 companies in 2025. Trend: 2023 $675 · 2024 $684 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $286 |
| Edwards Lifesciences Corporation | 2 | $172 |
| PFIZER INC. | 3 | $68 |
| Novo Nordisk Inc | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| MERZ NORTH AMERICA, INC. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: VRAYLAR, BOTOX, Kerendia, NURTEC ODT, Ozempic, INJECTAFER, MOUNJARO, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
